Parallel with these findings, we also found significantly increased pro-inflammatory cytokine IL-6 and IL-8 from pancreatic cancer patients compared to control, indicating the high probability of an activated NFkB pathway in these patients. Here, NFKB1 is linked to pancreatic neoplasm.